Información del artículo
Resumen
La endometriosis es una de las enfermedades más enigmáticas y controvertidas de la ginecología y, por ello, no existe un tratamiento idóneo para la misma, especialmente cuando hay que preservar la fertilidad de la mujer. Las terapéuticas aplicadas a la paciente con endometriosis van dirigidas a suprimir el dolor o a tratar la esterilidad asociada. Sin embargo, la aplicación de los diferentes tratamientos se ha basado con frecuencia en métodos empíricos o en estudios observacionales. El objetivo de este artículo es analizar la evidencia disponible en la bibliografía actual acerca del valor real del tratamiento, tanto médico como quirúrgico, en el manejo de la paciente con endometriosis.
Palabras clave:
Endometriosis
Esterilidad
Medicina basada en la evidencia
Tratamiento médico
Tratamiento quirúrgico
Summary
Endometriosis is one of the most enigmatic and controversial gynecological diseases and consequently an ideal treatment is lacking, especially when fertility must be preserved. The therapies given to women with endometriosis aim to eliminate pain or treat associated infertility. However, the application of the various treatments has frequently been based on empiricism or observational studies. The present article aims to analyze the evidence currently available in the literature on the real value of both surgical and medical treatment in the management of patients with endometriosis.
Keywords:
Endometriosis
Infertility
Evidence-based medicine
Medical treatment
Surgical treatment
El Texto completo está disponible en PDF
Bibliografía
[1.]
P. Vercellini, G. Ragni, L. Trespidi, S. Oldani, P.G. Crosignani.
Does contraception modify the risk of endometriosis?.
Hum Reprod, 8 (1993), pp. 547-551
[2.]
M.P. Vessey, L. Villard-Mackintosh, R. Painter.
Epidemiology of endometriosis in women attending family planning clinics.
Br Med J, 306 (1993), pp. 182-184
[3.]
F. Parazzini, M. Ferraroni, L. Bocciolone, L. Tozzi, S. Rubessa, C. La Vechia.
Contraceptive methods and risk of pelvic endometriosis.
Contraception, 49 (1994), pp. 47-55
[4.]
J. Balasch, M. Creus, F. Fábregues, F. Carmona, J. Ordi, S. Martínez-Román, et al.
Visible and non-visible endometriosis at laparoscopy in fertile and infertile women and in patients with chronic pelvic pain: a prospective study.
Hum Reprod, 11 (1996), pp. 387-391
[5.]
D.L. Olive.
Analysis of clinical fertility trials: a methologic review.
Fertil Steril, 45 (1986), pp. 157-171
[6.]
J. Balasch, P. Viscasillas.
Endometriosis y esterilidad.
pp. 89-106
[7.]
D.L. Olive, E.R. Pritts.
Treatment of endometriosis.
N Engl J Med, 345 (2001), pp. 266-275
[8.]
Endometriosis: absence of recurrence in patients after endometrial ablation.
Hum Reprod, 16 (2001), pp. 2676-2679
[9.]
J.A. Sampson, N.Y. Albany.
Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity.
Am J Obstet Gynecol, 14 (1927), pp. 422-469
[10.]
S. Telimaa, J. Puolakka, L. Ronnberg, A. Kauppila.
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treament of endometriosis.
Gynecol Endocrinol, 1 (1987), pp. 13-23
[11.]
A.M. Dlugi, J.D. Miller, J. Knittle.
Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study.
Fertil Steril, 54 (1990), pp. 419-427
[12.]
L. Fedele, S. Bianchi, L. Bocciolone, G. Di Nola, D. Franchi.
Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study.
Fertil Steril, 59 (1993), pp. 516-521
[13.]
C.E. Overton, P.C. Lindsay, B. Johal, S.A. Collins, N.C. Siddle, R.W. Shaw, et al.
A randomized, double-blind, placebo-controlled study of luteal phase dehydorgesterone (Duphaston) in women with minal to mild endometriosis.
Fertil Steril, 62 (1994), pp. 701-707
[14.]
Anonymus.
Goserelin depot versus danazol in the treatment of endometriosis: the Australian/New Zealand experience.
Aust NZJ Obstet Gynaecol, 36 (1996), pp. 55-60
[15.]
S.P. Chang, H.T. Ng.
A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis.
Clin Med J, 57 (1996), pp. 431-437
[16.]
U.H. Cirkel, H. Oochs, H.P.G. Schneider.
A randomized, comparative trial of triptorelin depot (D-Trp6-LHRH) and danazol in the treatment of endometriosis.
Eur J Obstet Gynecol Reprod Biol, 59 (1995), pp. 61-69
[17.]
P.G. Crosignani, A. Gastaldi, P.L. Lombardi.
Leuprorelin acetate depot versus danazol in the treatment of endometriosis: results of an open multicentre trial.
Clin Ther, 14 (1992), pp. 29-36
[18.]
W.P. Dmowski, E. Radwanska, Z. Binor, I. Tummon, P. Pepping.
Ovarian suppression induced with buserelin or danazol in the management of endometriosis: a randomized, comparative study.
Fertil Steril, 51 (1989), pp. 395-400
[19.]
I.S. Fraser, R.P. Shearman, R.P. Jansen, P.D. Shuterland.
A comparative treatment trial of endometriosis using the gonadotropinreleasing hormone agonist, nafarelin, and the synthetic steroid, danazol.
Aust NZJ Obstet Gynaecol, 31 (1991), pp. 158-163
[20.]
M.R. Henzl, S.L. Corson, K. Moghissi, V.C. Buttram, C. Berqvist, J. Jacobson.
Administration of nasal nafarelin as compared with oral danazol for endometriosis: a multcenter double-blind comparative clinical trial.
N Engl J Med, 318 (1988), pp. 485-489
[21.]
G.D.L. Adamson, L. Kwei, R.A. Edgren.
Pain of endometriosis: effects of nafarelin and danazol therapy.
Int J Fertil Med Stud, 39 (1994), pp. 215-217
[22.]
J.M. Wheeler, J.D. Knittle, J.D. Miller.
Depot leuprolide versus danazol in treatment of women with symptomatic endometriosis (I). Efficacy results.
Am J Obstet Gynecol, 167 (1992), pp. 1367-1371
[23.]
M.Y. Dawood, J. Ramos, F.S. Khan-Dawood.
Depot leuprolide acetate versus danazol for treatment of pelvic endometriosis: changes in vertebral bone mass and serum estradiol and calcitonin.
Fertil Steril, 63 (1995), pp. 1177-1183
[24.]
The Nafarelin European Endometriosis Trial Group (NEET).
Nafarelin for endometriosis: a large-scales, danazol-controlled trial of efficacy and safety, with 1-year follow-up.
Fertil Steril, 57 (1992), pp. 514-522
[25.]
R. Rolland, P.F. Van der Heijden.
Nafarelin versus danazol in the treatment of endometriosis.
Am J Obstet Gynecol, 162 (1990), pp. 586-588
[26.]
S.H. Kennedy, I.A. Williams, J. Brodribb, D.H. Barlow, R.W. Shaw.
A comparison of nafarelinacetate and danazol in the treatment of endometriosis.
Fertil Steril, 53 (1990), pp. 998-1003
[27.]
J.A. Rock.
A multicenter comparison of GnRH agonist (Zoladex) and danazol in the treatment of endometriosis.
Fertil Steril, 56 (1991), pp. 49
[28.]
R.W. Shaw.
An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis: Zoladex Endometriosis Study Team.
Fertil Steril, 58 (1992), pp. 265-272
[29.]
A. Prentice, A. Deery, S. Goldbeck-Wood, C. Farquhar, S. Smith.
Gonadotropin-releasing hormone analogues for pain associated with endometriosis (Cochrane review).
The Cochrane library, issue 3,
[30.]
P. Vercellini, L. Trespidi, A. Colombo, N. Vendola, M. Marchini, P. Crosignani.
A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
Fertil Steril, 60 (1993), pp. 75-79
[31.]
E. Surrey, H. Judd.
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial.
J Clin Endocrinol Metab, 75 (1992), pp. 558-563
[32.]
L. Makarainen, L. Ronnberg, A. Kauppila.
Medroxyprogesterone acetate supplementation diminishes the hypoestrogenic side-effects of gonadotropin-releasing hormone agonists without changing its efficacy in endometriosis.
Fertil Steril, 65 (1996), pp. 29-34
[33.]
O. Taskin, A.H. Yakinoghe, S. Kucuk, I. Uryan, A. Buhur, F. Burak.
Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.
Fertil Steril, 67 (1997), pp. 40-45
[34.]
D. Edmonds, R. Howell.
Can hormone replacement therapy be used during medical therapy of endometriosis?.
Br J Obstet Gynecol, 101 (1994), pp. 24-26
[35.]
P. Kiiholma, R. Tuimala, S. Kivinen, M. Korhonen, E. Hagman.
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogens add-back therapy in the treatment of endometriosis.
Fertil Steril, 64 (1995), pp. 903-908
[36.]
K.S. Moghissi, W.D. Schlaff, D.L. Olive, M.A. Skinner, H. Yin.
Goserelin acetate (Zoladex) with or without hormone replacement therapy for the treatment of endometriosis.
Fertil Steril, 69 (1998), pp. 1056-1062
[37.]
E.S. Surrey, B. Voight, N. Fournet, H.L. Judd.
Prolonged gonadotropin releasing hormone agonist treatment of symptomatic endometriosis: the role of cycles sodium etidronate and low dose norethindrone ”add-back“ therapy.
Fertil Steril, 63 (1995), pp. 747-755
[38.]
M.D. Hornsterin, E.S. Surrey, G.W. Weisberg, L.A. Casino.
Lupron Add-Back Study Group. Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-mont study.
Obstet Gynecol, 91 (1998), pp. 16-24
[39.]
J. Balasch.
Análisis del empleo de los análogos de la GnRH (a-GnRH) en el tratamiento del mioma uterino.
Clin Invest Ginecol Obstet, 20 (1993), pp. 166-179
[41.]
C.J.G. Sutton, S.P. Ewen, N. Whitelaw, P. Haines.
Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis.
Fertil Steril, 62 (1994), pp. 696-700
[42.]
M.L. Wilson, C.M. Farquhar, O.J. Sinclair, N.P. Johnson.
Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhea (Cochrane review).
The Cochrane Library. issue 1,
[43.]
G.B. Candiani, L. Fedele, P. Vercellini, S. Bianchi, G. Di Nola.
Presacral neurectomy for the treatment of pelvic pain associated with endometriosis: a controlled study.
Am J Obstet Gynecol, 167 (1992), pp. 100-103
[44.]
B. Tjaden, W.D. Schlaff, A. Kimball, J.A. Rock.
The efficacy of presacral neurectomy for the relief of midline dysmenorrhea.
Obstet Gynecol, 76 (1990), pp. 89-91
[45.]
P. Vercellini, O. De Giorgi, A. Pisacreta, A.P. Pesole, S. Vicentini, P.G. Crosignani.
Surgical management of endometriosis.
Baillière's Clin Obstet Gynecol, 14 (2000), pp. 501-523
[46.]
S. Telimaa, L. Ronnberg, A. Kauppila.
Placebo-controlled comparion of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis after conservative surgery.
Gynecol Endocrinol, 1 (1987), pp. 363-371
[47.]
M.D. Hornstein, R. Hemmings, A.A. Yuzpe, W.L. Heinrichs.
Use of nafarelin versus placebo after reductive laparoscopic surgery for endometriosis.
Fertil Steril, 68 (1997), pp. 860-864
[48.]
F. Parazzini, L. Fedele, M. Busacca, L. Falsetti, S. Pellegrini, P.L. Venturini, et al.
Postsurgical medical treatment of advanced endometriosis: results of a randomized clinical trial.
Am J Obstet Gynecol, 171 (1994), pp. 1205-1207
[49.]
L. Muzii, R. Marana, P. Caruana, S. Mancuso.
The impact of preoperative gonadotropin-releasing hormone agonist treatment on laparoscopic excision of ovarian endometriotic cysts.
Fertil Steril, 65 (1996), pp. 1235-1237
[50.]
J. Donnez, M. Nisolle, F. Clerkx, J. Sandow, F. Casanas-Roux.
Administration of nasal buserelin as compared with subcutaneous buserelin implant for endometriosis.
Fertil Steril, 52 (1989), pp. 27-30
[51.]
P.C. Crosignani, G. Aimo, P. Vercellini, M. Meschia.
Hysterectomy for benign gynecologic disorders: when and why?.
Postg Med, 100 (1996), pp. 133-140
[52.]
T.G. Stovall, F.W. Ling, D.A. Crawford.
Hysterectomy for chronic pelvic pain of presumed uterine etiology.
Obstet Gynecol, 75 (1990), pp. 676-679
[53.]
R.W. Beard, R.G. Kennedy, K.F. Gangar.
Bilateral oofphorectomy and hysterectomy in the treatment of intractable pelvic pain associated with pelvic congestion.
Br J Obstet Gynaecol, 98 (1991), pp. 988-992
[54.]
K.J. Carlson, B.A. Miller, F.J. Fowler.
Tha Maine women's health study (I). Outcomes of hysterectomy.
Obstet Gynecol, 83 (1994), pp. 556-565
[55.]
S.D. Hillis, P.A. Marchbanks, H.B. Peterson.
The effectiveness of hysterectomy for chronic pelvic pain.
Obstet Gynecol, 86 (1995), pp. 941-945
[56.]
S.K. Tay, N. Bromwich.
Outcome of hysterectomy for pelvic pain in premenopausal women.
Aust NZJ Obstet Gynaecol, 38 (1998), pp. 72-76
[57.]
A.B. Namnoum, T.N. Hickman, S.B. Goodman, D.L. Gehlbach, J.A. Rock.
Incidence of symptom recurrence after hysterectomy for endometriosis.
Fertil Steril, 64 (1995), pp. 898-902
[58.]
ACOG Practice Bulletin.
Medical Management of endometriosis,
[59.]
F. Gucer, D. Pieber, M.G. Arikan.
Malignancy arising in extraovarian endometriosis during estrogen stimulation.
Eur J Gynaecol Oncol, 19 (1998), pp. 39-41
[60.]
S.R. Bayer, M.M. Seibel, D.S. Saffan, M.J. Berger, M.L. Taymor.
Efficacy of danazol treatment for minimal endometriosis in infertile women: a prospective, randomized study.
J Reprod Med, 33 (1988), pp. 179-183
[61.]
L. Fedele, F. Parazini, E. Radici, L. Bocciolone, S. Bianchi, C. Bianchi, et al.
Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial.
Am J Obstet Gynecol, 166 (1992), pp. 1345-1350
[62.]
S. Telimaa.
Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis.
Fertil Steril, 50 (1988), pp. 872-876
[63.]
E.J. Thomas, I.D. Cooke.
Successful treatment of asymptomatic endometriosis: does it benefit infertile women?.
BMJ, 294 (1987), pp. 1117-1119
[64.]
E. Hughes, D. Fedorkow, J. Collins, P. Vandekerckhone.
Ovulation suppression for endometriosis.
The Cochrane Library. issue 1,
[65.]
A.D. Noble, A.T. Letchworth.
Medical treatment of endometriosis: a comparative trial.
Postgrad Med J, 55 (1979), pp. 37-39
[66.]
L. Fedele, S. Bianchi, L. Arcaini, P. Vercellini, G.B. Candiani.
Buserelin versus danazol in the treatment of endometriosis-associated infertility.
Am J Obstet Gynecol, 161 (1989), pp. 871-876
[67.]
L. Fedele, S. Bianchi, T. Viezzoli, L. Arcaini, G.B. Candiani.
Gestrinone versus danazol in the treatment of endometriosis.
Fertil Steril, 51 (1989), pp. 781-785
[68.]
D.L. Olive, K.L. Lee.
Analysis of sequential treatment protocols for endometriosis-associated infertility.
Am J Obstet Gynecol, 154 (1986), pp. 613-619
[69.]
G.D. Adamson, D.J. Pasta.
Surgical treatment of endometriosisassociated infertility: meta-analysis compared with survival analysis.
Am J Obstet Gynecol, 171 (1994), pp. 1488-1505
[70.]
E.G. Hughes, D.M. Fedorkow, J.A. Collins.
A quantitative overview of controlled trials in endometriosis-associated infertility.
Fertil Steril, 59 (1993), pp. 963-970
[71.]
S. Marcoux, R. Maheux, S. Berube, and The Canadian Collaborative Group on Endometriosis.
Laparoscopic surgery in infertile women with minimal or mild endometriosis.
N Engl J Med, 337 (1997), pp. 217-222
[72.]
J. Balasch.
Tratamiento actual de la esterilidad asociada a la endometriosis.
Clin Invest Ginecol Obstet, 25 (1998), pp. 144-150
[73.]
S. Bérubé, S. Marcoux, M. Langevin, R. Maheux.
and The Canadian Collaborative Group on Endometriosis Fecundity of infertile women with minimal or mild endometriosis and women with unexplained infertility.
Fertil Steril, 69 (1998), pp. 1034-1041
[74.]
F. Parazzini.
Gruppo Italiano per lo Studio dell'Endometriosi. blation of lesions or no treatment in minimal-mild endometriosis in infertile women: a randomized trial.
Hum Reprod, 14 (1999), pp. 1332-1334
[75.]
L. Fedele, S. Bianchi, M. Marchini, L. Villa, D. Brioschi, F. Parazinni.
Superovulation with human menopausal gonadotropins in the treatment of infertility associated with minimal or mild endometriosis: a controlled randomized study.
Fertil Steril, 58 (1992), pp. 28-31
[76.]
J.L. Deaton, M. Gibson, K.M. Blackmer, S.T. Nakajima, G.J. Badger, J.R. Brumsted.
A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis.
Fertil Steril, 54 (1990), pp. 1083-1088
[77.]
I.S. Tummon, L.J. Asher, J.S. Martin, T. Tulandi.
Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis.
Fertil Steril, 68 (1997), pp. 8-12
[78.]
S. Soliman, S. Daya, J. Collins, J. Jarrell.
A randomized trial of in vitro fertilization versus conventional treatment for infertility.
Fertil Steril, 59 (1993), pp. 1239-1244
[79.]
H. Kodama, J. Fukuda, H. Karube, T. Matsui, Y. Shimizu, T. Tanaka.
Benefit of in vitro fertilization treatment for endometriosis-associated infertility.
Fertil Steril, 66 (1996), pp. 974-979
[80.]
J.L. Mergui, L. Boubli, N. Perrot, M. Bazot, S. Uzan, et al.
Adénomyose: diagnostic, fréquence et place dans les ménométrorragies.
L'endométriose, pp. 84-94
[81.]
T. Tulandi.
Adenomyosis: an old disease deserving new attention.
Hum Reprod Update, 4 (1998), pp. 311
[82.]
C. Wood.
Surgical and medical treatment of adenomyosis.
Hum Reprod Update, 4 (1998), pp. 323-326
[83.]
L. Fedele, S. Bianchi, R. Raffaeli, A. Portuese, M. Dorta.
Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device.
Fertil Steril, 68 (1997), pp. 426-429
[84.]
G.P. Siskin, M.E. Tublin, B.F. Stainken, K. Dowling, E.G. Dolen.
Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging.
Am J Roentgenol, 177 (2001), pp. 297-302
Copyright © 2003. Sociedad Española de Ginecología y Obstetricia